NCT00209521 - Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions

Ischemic Coronary Artery DiseaseCoronary Artery Bypass Surgery

Interventions

DRUG

fospropofol

Using a Target Controlled Infusion (TCI) system, the target plasma concentrations of propofol to be administered from AQUAVAN were 0.7 μg/mL (sedation) and 2.5 μg/mL (maintain anesthesia).

DRUG

propofol

Using a Target Controlled Infusion (TCI) system, the target plasma concentrations of propofol to be administered from Disoprivan were 1.0 μg/mL (sedation) and 3.0 μg/mL (maintain anesthesia).